Jump to main content
Jump to site search

Issue 3, 2016
Previous Article Next Article

In silico-driven multicomponent synthesis of 4,5- and 1,5-disubstituted imidazoles as indoleamine 2,3-dioxygenase inhibitors

Author affiliations

Abstract

Indoleamine 2,3-dioxygenase is involved in pathological immune escape and has recently become an attractive target for anti-cancer therapy. 4-Phenylimidazole (4-PI) provides a promising starting point for the development of IDO1 inhibitors. With the aim of discovering more potent ligands, a virtual library of imidazoles synthesizable via the van Leusen multicomponent reaction was created and filtered to afford a set of 4,5- and 1,5-disubstituted imidazoles as virtual lead candidates. The compounds were selected according to their docking score and to their synthetic feasibility, synthesized and biologically evaluated. This experimental approach yielded IDO1 inhibitors with an enhanced potency compared to 4-PI; the most active compounds displayed a low micromolar potency, both in enzymatic and cellular assays, while showing no detectable cellular toxicity. A 3D quantitative structure–activity relationship based on the electrostatic and steric ligand–protein interactions was observed.

Graphical abstract: In silico-driven multicomponent synthesis of 4,5- and 1,5-disubstituted imidazoles as indoleamine 2,3-dioxygenase inhibitors

Back to tab navigation

Supplementary files

Publication details

The article was received on 31 Jul 2015, accepted on 02 Oct 2015 and first published on 08 Oct 2015


Article type: Research Article
DOI: 10.1039/C5MD00317B
Author version
available:
Download author version (PDF)
Citation: Med. Chem. Commun., 2016,7, 409-419
  •   Request permissions

    In silico-driven multicomponent synthesis of 4,5- and 1,5-disubstituted imidazoles as indoleamine 2,3-dioxygenase inhibitors

    S. Fallarini, A. Massarotti, A. Gesù, S. Giovarruscio, G. Coda Zabetta, R. Bergo, B. Giannelli, A. Brunco, G. Lombardi, G. Sorba and T. Pirali, Med. Chem. Commun., 2016, 7, 409
    DOI: 10.1039/C5MD00317B

Search articles by author

Spotlight

Advertisements